October 07, 2026 06:42 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘Vote thief’ Gyanesh Kumar: Rahul Gandhi climbs barricade, waves Tricolour during explosive INDIA bloc protest | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘He should not have been flying’: JD Vance on Flydubai co-pilot | Israel was ready to shoot down Flydubai jet if it kept flying towards Tel Aviv: Reports | 'If law wasn't followed, we can undo it': Supreme Court's big warning on SIR process amid Gyanesh Kumar row | From TMC Rajya Sabha MP to BJP nominee in 6 months: Koel Mallick's stunning political U-turn | ‘Stomp on your head’: Omani flydubai co-pilot’s chilling posts on violence against women surface | Asian Games 2026: India beat Pakistan to clinch gold in men's cricket | flydubai cockpit attack: Deleted posts expose Omani co-pilot’s views on women, alleged extremist past
AstraZeneca
WIKIMEDIA COMMONS

WHO to hold meeting on AstraZeneca Vaccine safety on Tuesday

| @indiablooms | Mar 16, 2021, at 02:42 pm

Geneva/Sputnik: The World Health Organization's (WHO) global advisory committee on vaccine safety will hold a meeting on Tuesday on the safety of the AstraZeneca vaccine, WHO Director General Tedros Adhanom Ghebreyesus said.

"The WHO's advisory committee on vaccine safety has been reviewing the available data, is in close contact with the European Medicines Agency and will meet tomorrow," Tedros said at a briefing.

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has scheduled an extraordinary meeting for March 18, during which it intends to evaluate all recent incidents related to vaccinations with AstraZeneca, the regulator said.

"EMA’s safety committee (PRAC) will further review the information tomorrow (Tuesday) and has called an extraordinary meeting on Thursday 18 March to conclude on the information gathered and any further actions that may need to be taken," the statement says.

EMA also confirmed that during the investigation, the regulator proceeds from the position that the benefits of the AstraZeneca vaccine outweigh the risks associated with it.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.